SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting
March 21, 2025
 · 
6 min read
Press Releases
Syneron Bio Announces Strategic Collaboration with AstraZeneca
March 21, 2025
 · 
1 min read
Press Releases
BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025
March 21, 2025
 · 
1 min read
Press Releases
iECURE Announces Presentation of Full Data for the First Infant Dosed with ECUR-506 in OTC-HOPE Phase 1/2 Clinical Trial at the 2025 ACMG Annual Clinical Genetics Meeting
March 21, 2025
 · 
6 min read
Press Releases
Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance
March 21, 2025
 · 
5 min read
Press Releases
Clearmind Medicine’s FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key Milestones
March 21, 2025
 · 
4 min read
Press Releases
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2024 Results on March 26, 2025
March 21, 2025
 · 
1 min read
Press Releases
STRATA Skin Sciences to Report Fourth Quarter and Year End 2024 Financial Results on March 27, 2025 and Provide Corporate Update
March 21, 2025
 · 
3 min read
Press Releases
Baylor Genetics Presents New Data on Genetic and Functional Testing to Diagnose Mitochondrial Disorders at 2025 ACMG Annual Clinical Genetics Meeting
March 21, 2025
 · 
3 min read
Press Releases
Annovis Provides Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
March 21, 2025
 · 
6 min read
Press Releases
DotBio joins JLABS South San Francisco
DotBio has been accepted into Johnson & Johnson’s global incubator network, JLABS South San Francisco.
March 21, 2025
 · 
1 min read
Press Releases
FDA Approves New Prostate Cancer Imaging Agent Gozellix®
March 21, 2025
 · 
10 min read
Press Releases
HUTCHMED Announces NMPA Conditional Approval for TAZVERIK® (tazemetostat) for the Treatment of Relapsed or Refractory Follicular Lymphoma
March 21, 2025
 · 
8 min read
Press Releases
SANUWAVE Announces Record Quarterly Revenues: Q4 FY2024 Financial Results
March 21, 2025
 · 
16 min read
Press Releases
Chimerix Reports Fourth Quarter and Year End 2024 Financial Results
March 21, 2025
 · 
7 min read
Press Releases
Yaqrit secures NIHR grant for pivotal trials of its liver support device, DIALIVE, for patients with liver failure
March 21, 2025
 · 
5 min read
Press Releases
Antengene Announces 2024 Full-Year Financial Results, Proprietary Programs Advancing to Pivotal Trials with Accelerating Multi-market Revenue Ramp Up
March 21, 2025
 · 
10 min read
Press Releases
Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years
March 21, 2025
 · 
5 min read
Press Releases
Clearside Biomedical’s Lead Clinical Program CLS-AX in Wet AMD and Suprachoroidal Delivery Platform Highlighted at the 2025 Wet AMD & Diabetic Eye Disease Summit
March 21, 2025
 · 
7 min read
Press Releases
Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update
March 21, 2025
 · 
10 min read
Press Releases
Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
March 21, 2025
 · 
7 min read
Press Releases
Avalo Reports 2024 Financial Results and Recent Business Updates
March 21, 2025
 · 
10 min read
Press Releases
As Mpox Cases Spread Around the World, Tonix Pharmaceuticals’ Single-Dose Vaccine TNX-801 Has Potential to Slow the Spread
March 21, 2025
 · 
5 min read
Press Releases
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
March 21, 2025
 · 
11 min read
Press Releases
Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study in Metastatic Breast Cancer
March 21, 2025
 · 
4 min read
Press Releases
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) significantly outperforms standard of care in first-line EGFR-mutated lung cancer with compelling new data at ELCC 2025
March 21, 2025
 · 
32 min read
Press Releases
TiumBio’s Partner Hansoh Pharma Expands Indications for Merigolix (HS-10518) with Initiation of ART (Assisted Reproductive Technology) Development
March 21, 2025
 · 
3 min read
Press Releases
RAINIER Trial Data Update: Two Additional AML Patients Achieve Remission Within 30 Days of Treatment
March 21, 2025
 · 
10 min read
Press Releases
Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications
March 21, 2025
 · 
7 min read
Press Releases
Akeso’s Cadonilimab Combined with Concurrent Chemoradiotherapy Demonstrates Promising Efficacy in Locally Advanced Cervical Cancer: Data Published at the 2025 SGO Annual Meeting
March 21, 2025
 · 
2 min read
Press Releases
Angle PLC Announces Results of Eisai Phase 2 pilot study
March 21, 2025
 · 
7 min read
Press Releases
Enigma Biomedical USA, Inc. Announces Candidate Selection of Novel 4R Tau PET Imaging Biomarkers
March 21, 2025
 · 
2 min read
Press Releases
Can-Fite Partner Vetbiolix Accelerate Piclidenoson Development with Advanced Clinical Trial for Canine Osteoarthritis in a $3.8 Billion Market
March 21, 2025
 · 
7 min read
Press Releases
Rentschler Biopharma appoints Robert Panting as VP Global Client Program Management and Strategy
March 21, 2025
 · 
3 min read
Load More